ArticleCancers2025

CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.

Daniele Caracciolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.